TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma
Cancer Science · 2023
DOI: 10.1111/cas.15852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Caifeng Yue und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Innovatio…. Hauptthemen laut MEDLINE: Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Epigenetic alterations marked by DNA methylation are frequent events during the early development of nasopharyngeal carcinoma (NPC). We identified that TRIM29 is hypomethylated and overexpressed in NPC cell lines and tissues. TRIM29 silencing not only limited the growth of NPC cells in vitro and in vivo, but also induced cellular senescence, along with reactive oxygen species (ROS) accumulation. Mechanistically, we found that TRIM29 interacted with voltage‐dependent anion‐selective channel 1 (VDAC1) to activate mitophagy clearing up damaged mitochondria, which are the major source of ROS. In patients with NPC, high levels of TRIM29 expression are associated with an advanced clinical stage. Moreover, we detected hypomethylation of TRIM29 in patient nasopharyngeal swab DNA. Our findings indicate that TRIM29 depends on VDAC1 to induce mitophagy and prevents cellular senescence by decreasing ROS. Detection of aberrantly methylated TRIM29 in the nasopharyngeal swab DNA could be a promising strategy for the early detection of NPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharynge…
- Department of Laboratory Medicine, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China.
- Institute of Anatomy, University of Bern, Bern, Switzerland.
- Gastrointestinal Institute, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Cancer Epigenetics Program, Anhui Cancer Hospital, Hefei, China.
- Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong K…
ORCID-Profile: Caifeng Yue, Jiewei Chen, Jing Wang, Xiangbo Wan
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Shenzhen Bay Laboratory Research Funds
Zitieren
APA
Yue, C., Qian, Y., Wang, C., Chen, J., Wang, J., Wang, Z., Wan, X., Cao, S., Zhu, J., Tao, Q., Yan, M., & Liu, Q. (2023). TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. https://doi.org/10.1111/cas.15852
Vancouver
Yue C, Qian Y, Wang C, Chen J, Wang J, Wang Z, et al. TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. 2023. doi:10.1111/cas.15852
BibTeX
@article{Yue2023,
author = {Yue, Caifeng and Qian, Yuanmin and Wang, Chang and Chen, Jiewei and Wang, Jing and Wang, Zifeng and Wan, Xiangbo and Cao, Sumei and Zhu, Jingde and Tao, Qian and Yan, Min and Liu, Quentin},
title = {TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15852}
}
EUVIMED